ReviewAsian journal of andrology2025
Recent advances in the management of male infertility.
Review in Asian journal of andrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mechanisms of Polystyrene Microplastics in Multipathway Disruption of the Blood-Testis Barrier.Andrology · 2026Article
- Integrating multi-omics and network toxicology to identify FIS1 as a key target of environmental pollutants in male infertility.Frontiers in cell and developmental biology · 2026Article
- PRDX1 promotes testosterone synthesis and attenuates aging via redox regulation of ATG4B to modulate lipophagy.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractMale factor infertility has been rising, which accounts for up to 30% of infertility cases and contributes to 50% of overall cases. The aim of this review is to explore the recent advances that have emerged in the field through a narrative review. A comprehensive literature search was conducted using multiple databases, including the Cochrane Library, PubMed, Scopus, and Web of Science. Gray literature was also reviewed through ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform. The findings were presented narratively to encompass the extensive range of published data on male infertility. Significant strides have been made in the field of male infertility, particularly with biomarkers, shear wave elastography, 3-dimensional (3D) bioprinting, artificial intelligence (AI), and robotic and microsurgical treatment, offering promising avenues for diagnosis and treatment. Continued research and technological innovation are essential to further improve outcomes for patients facing male factor infertility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.